| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Innoviva, Inc. (INVA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. INVA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 162.3K | $3.65M | - | |
| CFO | 51.3K | $1.15M | - | |
| Other | 48.3K | $1.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2018 | Desparbes Eric | Interim Peo, SVP And CFO | Sell | 5,378 | $16.52 | $88,825.20 | -1.8% | |
| Feb 21, 2018 | Witek Theodore J. Jr. | Sr. VP &Chief Scientific Off. | Sell | 9,890 | $16.60 | $164,148.29 | -5.0% | |
| Feb 21, 2018 | Abercrombie George B68 | Sr. VP &Chief Comm. Officer | Sell | 8,000 | $16.51 | $132,100.00 | -3.3% | |
| Dec 4, 2017 | Aguiar Michael W | President &Chief Exec Officer | Sell | 12,022 | $13.13 | $157,791.15 | -1.2% | |
| Nov 21, 2017 | Desparbes Eric | SVP And CFO | Sell | 15,285 | $13.28 | $202,969.44 | -2.3% | |
| Nov 21, 2017 | Witek Theodore J. Jr. | Sr. VP &Chief Scientific Off. | Sell | 13,000 | $13.29 | $172,794.70 | -5.7% | |
| Nov 21, 2017 | Abercrombie George B68 | Sr. VP &Chief Comm. Officer | Sell | 5,215 | $13.26 | $69,145.16 | -2.0% | |
| Aug 21, 2017 | Desparbes Eric | SVP And CFO | Sell | 1,825 | $12.20 | $22,265.00 | -0.5% | |
| May 22, 2017 | Witek Theodore J. Jr. | Sr. VP &Chief Scientific Off. | Sell | 7,815 | $12.01 | $93,858.15 | -3.1% | |
| May 22, 2017 | Desparbes Eric | SVP And CFO | Sell | 1,825 | $11.85 | $21,626.25 | -0.5% |